Life Science REIT PLC (LABS) - Total Liabilities
Based on the latest financial reports, Life Science REIT PLC (LABS) has total liabilities worth GBX141.89 Million GBX (≈ $17.26K USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore how much of Life Science REIT PLC's assets are long-term investments to see how much of total assets are deployed in long-term investments.
Life Science REIT PLC - Total Liabilities Trend (2021–2024)
This chart illustrates how Life Science REIT PLC's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Life Science REIT PLC asset portfolio.
Life Science REIT PLC Competitors by Total Liabilities
The table below lists competitors of Life Science REIT PLC ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
ALLIANCE ONE INT
F:DM8
|
Germany | €3.13 Million |
|
Cynata Therapeutics Ltd
AU:CYP
|
Australia | AU$1.22 Million |
|
ETRUSCUS RESOURCES CORP.
F:ERR
|
Germany | €189.69K |
|
Fintech Chain Ltd
AU:FTC
|
Australia | AU$54.97 Million |
|
Subgen AI
ST:SUBGEN
|
Sweden | Skr199.12 Million |
|
Middlefield Canadian Income PCC - Middlefield Canadian Income - GBP PC
LSE:MCT
|
UK | GBX28.28 Million |
|
Monarca Minerals Inc
V:MMN
|
Canada | CA$6.00 Million |
Liability Composition Analysis (2021–2024)
This chart breaks down Life Science REIT PLC's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See LABS equity financing ratio to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | N/A | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.61 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.38 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Life Science REIT PLC's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Life Science REIT PLC (2021–2024)
The table below shows the annual total liabilities of Life Science REIT PLC from 2021 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | GBX138.42 Million ≈ $16.84K |
+9.03% |
| 2023-12-31 | GBX126.96 Million ≈ $15.45K |
-1.10% |
| 2022-12-31 | GBX128.37 Million ≈ $15.62K |
+1086.45% |
| 2021-12-31 | GBX10.82 Million ≈ $1.32K |
-- |
About Life Science REIT PLC
Life Science REIT plc is a specialist property business focused on the UK's growing life science sector. The Company's portfolio of assets is located across the Golden Triangle of research and development hubs in Oxford, Cambridge and London's Knowledge Quarter. Life Science REIT trades on the Main Market of the London Stock Exchange under the ticker LABS.